Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
Sponsor: Alnylam Pharmaceuticals
Summary
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics (PD) and pharmacokinetics (PK) of zilebesiran in Japanese patients with mild to moderate hypertension.
Official title: A Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-06-05
Completion Date
2025-07-17
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
Zilebesiran
Zilebesiran administered by subcutaneous (SC) injection
Placebo
Placebo administered by SC injection
Locations (3)
Clinical Trial Site
Fukuoka, Japan
Clinical Trial Site
Osaka, Japan
Clinical Trial Site
Tokyo, Japan